Shuttle Pharmaceuticals Holdings, Inc.
SHPH Nasdaq
SEC CIK 1757499
Follow Shuttle Pharmaceuticals
Weekly email: filings, results
Net income
−$3.1M
+15.1% vs same quarter last year
EPS, diluted
−$3.10
Operating cash flow
−$567.6K
+83.1% vs same quarter last year
Operating income
−$3.9M
−1% vs same quarter last year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | −$11.7M |
| FY24 | −$9.1M |
| FY23 | −$6.6M |
| FY22 | −$5M |
| FY21 | −$1.2M |
| FY20 | - |